How biotech firms plan to ensure diversity in Covid-19 vaccine trials

CNBC's Meg Tirrell reports on plans from biotech companies and other organizations plan to ensure that individuals from communities hard-hit from the coronavirus pandemic receive proper representation during phase-3 trials for Covid-19 vaccines.
Mon, Jul 27 202011:00 AM EDT